Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accidental, agonist, ALIMTA®utilization, Alzheimer, anniversary, API, apoptotic, Arabia, atropine, Benchmark, binding, bore, borrow, borrowed, borrowing, calcium, Carolina, Chancery, CNS, codified, collateralized, diagnosed, doctrine, downregulating, duty, Elite, ER, Evanston, fiduciary, forum, greatest, half, HealthSystem, hypothesized, Impax, implicit, inapplicable, injury, intracellular, jennifer, led, LIBO, Lupin, main, mechanism, Mediation, midazolam, Middle, multiplied, NA, NaN, neuropathology, NorthShore, NYFRB, ODD, OOPD, organophosphate, oxime, pancreatic, Pennsylvania, people, pilot, pivotal, poised, poisoning, potent, PPACA, rat, remanded, reorder, rescheduled, rescinded, retention, rodent, Saudi, shortly, simpson, soman, Spring, survival, Surviving, task, TBI, today, traumatic, Tyme, uncapped, underserved, undrawn, University, USAMRICD, waiver, week, worsened
Removed:
acknowledgment, acumen, aim, Albany, allocating, Amy, antibody, approached, attractive, biobetter, biotech, Blair, BPCIA, carried, carryforward, cascading, catastrophic, Center, clarifying, closed, combine, comparing, concept, consummate, convenient, deductible, deducting, define, deterring, dialog, diclofenac, disruptive, diverse, extending, extrapolated, footprint, founded, GlaxoSmithKline, GSK, Hatch, headcount, HIT, hope, indemnification, India, inhibitor, integrating, interchangeable, investor, IP, Jaffray, joinder, Kendall, Krill, LDA, library, lump, mAb, MDCO, mg, mitigate, monoclonal, needle, negotiation, optimization, originally, outlook, output, overseeing, pain, payer, pediatric, persistent, Piper, pole, proof, prophylactic, protein, Pvt, qualitative, redeemed, regain, relieved, remediation, Representative, retroactively, ring, Sanofi, SC, Schulman, screen, situation, sling, Steven, strain, subcutaneously, sum, supplied, tentatively, TherDose, thirty, threefold, thrombin, thrombocytopenia, translated, unbranded, underwriter, underwriting, underwritten, waiting, Waxman, William, world
Filing tables
Filing exhibits
Related press release
Associated EGRX transcripts
EGRX similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
Eagle Pharmaceuticals, Inc.
Woodcliff Lake, New Jersey
We hereby consent to the incorporation by reference in the Registration Statement on Form S--3 (Nos. 333-234742 and 333-202592) and Form S-8 (Nos. 333-228876, 333-216839, 333-213683, 333-206729 and 333-194056) of Eagle Pharmaceuticals, Inc. (the “Company”) of our reports dated March 2, 2020, relating to the consolidated financial statements, and the effectiveness of the Company’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Woodbridge, New Jersey
March 2, 2020